-
Medication Use in Indolent Systemic Mastocytosis (ISM) in Germany Prior to Avapritinib EMA Approval
Sep 9, 2025, 16:22 PM -
Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey
Sep 9, 2025, 16:22 PM -
Management of Biliary Tract Cancer: A Modified Delphi (Consensus) Survey of UK Clinical Experts
Sep 9, 2025, 16:22 PM -
Assessing Patient Access to Psoriasis Treatments in Central, South, and Eastern European Countries: Insights and Disparities?
Sep 9, 2025, 16:22 PM -
Establishing the Relationship Between the Worst Itch Numerical Rating Scale and EQ-5D Utility in Patients With Primary Biliary Cholangitis Experiencing Pruritus: Pooled Results From GLIMMER and the PRO Validation Study
Sep 9, 2025, 16:22 PM -
The Acceptability of Wearables in Remote Monitoring According to Health Technology Assessment HTA Bodies
Sep 9, 2025, 16:22 PM -
Leveraging AI for Evidence Synthesis: Assessing the Accuracy and Efficiency of AI-Supported Data Extraction and Reporting
Sep 9, 2025, 16:22 PM -
Matching Adjusted Indirect Comparison of Asciminib vs. Flumatinib as First-Line Treatment for Chronic Myeloid Leukemia in China
Sep 9, 2025, 16:22 PM -
Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions
Sep 9, 2025, 16:22 PM -
Incidence and Treatment of Squamous-Cell Anal Cancer (SCAC) in Germany: A Retrospective Study in German Statutory Health Insurance (SHI) Claims Data
Sep 9, 2025, 16:22 PM -
Assessing the Cost-Effectiveness of Lecanemab for Early Alzheimer's Disease Treatment: A Swiss Perspective
Sep 9, 2025, 16:22 PM -
Multi-Country Survey to Explore Clinicians Experiences on a New Imaging Technology for Gastrointestinal Endoscopes and Its Impact on Detection and Resection of Lesions
Sep 9, 2025, 16:22 PM -
Development and Application of a JCA-Alignment Checklist for Early Economic Modeling in EU HTA
Sep 9, 2025, 16:22 PM -
The Health Impact of Pembrolizumab in Combination With Chemotherapy for the First-Line Treatment of Patients With Squamous Metastatic Non-Small Cell Lung Cancer (mNSCLC) in Türkiye
Sep 9, 2025, 16:22 PM -
Assessing Different Procurement Models for Automated Insulin Delivery (AID) Systems Using a Multicriteria Decision Analysis (MCDA)-Based Framework
Sep 9, 2025, 16:22 PM -
Global Payer Policies Potentially Impacting Pharma Pricing and Market Access Strategies: A Review of Five Key Trends Shaping Pharma Future
Sep 9, 2025, 16:22 PM -
Cardioprotective Medication Use Among Diabetic Patients With ASCVD in Qatar's Primary Care Setting
Sep 9, 2025, 16:22 PM -
Optimizing Market Access in Europe: A Comparative Analysis of Submission Templates from the EU JCA and National HTA Bodies (HAS, G-BA, ZIN, DMC)
Sep 9, 2025, 16:22 PM -
Vignette-Based Economic Models in UK HTA Submissions: Valuable Tool or Just NICE in Theory?
Sep 9, 2025, 16:22 PM -
Characterizing the Use of Janus Kinase Inhibitors (JAKi) in Five European Countries: A Drug Utilization Study
Sep 9, 2025, 16:22 PM
